Metal–Ligand Interactions: Overlooked Confounders in Antibiotic Discovery and Development
ACS Infectious Diseases · 10.04.2026 · 12 (4) · 1215-1217
DOI: 10.1021/acsinfecdis.6c00148 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 12.03.2026. Verfasst von Ziyi Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Metals. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Department of Medicinal Chemistry, University of Minnesota, Minneapolis Minnesota 55455, United States.
ORCID-Profile: Moyosore Oluseyi Orimoloye, Courtney C Aldrich, Anthony D Baughn
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases
Zitieren
APA
Jia, Z., Orimoloye, M. O., Aldrich, C. C., & Baughn, A. D. (2026). Metal–Ligand Interactions: Overlooked Confounders in Antibiotic Discovery and Development. ACS Infectious Diseases, 12(4), 1215-1217. https://doi.org/10.1021/acsinfecdis.6c00148
Vancouver
Jia Z, Orimoloye MO, Aldrich CC, Baughn AD. Metal–Ligand Interactions: Overlooked Confounders in Antibiotic Discovery and Development. ACS Infectious Diseases. 2026;12(4):1215-1217. doi:10.1021/acsinfecdis.6c00148
BibTeX
@article{Jia2026,
author = {Jia, Ziyi and Orimoloye, Moyosore Oluseyi and Aldrich, Courtney C and Baughn, Anthony D},
title = {Metal–Ligand Interactions: Overlooked Confounders in Antibiotic Discovery and Development},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {4},
pages = {1215--1217},
doi = {10.1021/acsinfecdis.6c00148}
}
EUVIMED